These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3686469)

  • 1. [Assessment of the severity and cost of adverse drug effects recorded at the Paris-Fernand Widal Drug Monitoring Center during 2 monthly periods].
    Castot A; Lagier G; Merigot P; de Crémoux P; Efthymiou ML
    Therapie; 1987; 42(4):365-7. PubMed ID: 3686469
    [No Abstract]   [Full Text] [Related]  

  • 2. [Critical analysis of the adverse effects reported to the Paris-Fernand Widal Drug Monitoring Center in a 2-month period].
    Castot A; Carlier P; Lagier G; Elmalem J; Vincens M; Efthymiou M
    Therapie; 1986; 41(5):375-7. PubMed ID: 3810528
    [No Abstract]   [Full Text] [Related]  

  • 3. [Risks related to the resorption of a glycine-based irrigation solution. 10 cases reported to the Poison Control Center and the Regional Center of Pharmacovigilance of Paris-Fernand-Widal].
    Bidault I; Maignen F; Estrache M; Castot A
    Therapie; 1993; 48(5):498-9. PubMed ID: 8146842
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of adverse effects of immuno-allergic nature at a Regional Pharmacovigilance Center].
    Sorbette F; Conte S; Montastruc JL
    Therapie; 1992; 47(5):445-6. PubMed ID: 1299998
    [No Abstract]   [Full Text] [Related]  

  • 5. [Microcomputerized data bank of nephrotoxic drugs at the Paris-Saint Antoine Regional Drug Monitoring Center].
    Hamel JD; Biour M; Cheymol G
    Therapie; 1986; 41(5):327-9. PubMed ID: 3810519
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems.
    Westerlund T; Marklund B
    J Clin Pharm Ther; 2009 Jun; 34(3):319-27. PubMed ID: 19646078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Report on adverse effects of drugs in Sweden 1965-70].
    Westerholm B
    Lakartidningen; 1971 Oct; 68():Suppl 3:31-40. PubMed ID: 5153809
    [No Abstract]   [Full Text] [Related]  

  • 8. [Activities of a regional drug monitoring center. What to evaluate, how and for what purpose].
    Péré JC; Haramburu F; Bégaud B; Barat C; Laborde B; Albin H
    Therapie; 1987; 42(4):351-8. PubMed ID: 3686468
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse drug reactions in hospital patients.
    Buechner JS
    Med Health R I; 1998 Feb; 81(2):60-1. PubMed ID: 9505068
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug fever--surprisingly common and costly.
    Harris LF; Holdsambeck HK
    Ala Med; 1986 Sep; 56(3):19-22. PubMed ID: 3776782
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug-induced discoloration of the teeth and gingiva].
    Mosimann P; Hartmann K; Kuhn M
    Praxis (Bern 1994); 1998 Mar; 87(12):413-6. PubMed ID: 9564238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differences in the relative incidence of adverse drug reactions in relation to age? An evaluation of the spontaneous reporting system of SANZ (Swiss Drug Monitoring Center)].
    Ciorciaro C; Hartmann K; Kuhn M
    Schweiz Med Wochenschr; 1998 Feb; 128(7):254-8. PubMed ID: 9540150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE ECONOMICS OF ADVERSE DRUG REACTIONS--case studies.
    Visconti JA; Smith MC
    Ann Pharmacother; 2006 Mar; 40(3):529-36. PubMed ID: 16507611
    [No Abstract]   [Full Text] [Related]  

  • 14. [Human acute poisoning data collection by Japan Poison Information Center].
    Kuroki Y
    Chudoku Kenkyu; 2005 Jul; 18(3):277-83. PubMed ID: 16119827
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacovigilance: characteristics of the most widely used drugs in Bulgaria.
    Getov I; Dimitrova Z
    Cent Eur J Public Health; 1999 Aug; 7(3):133-6. PubMed ID: 10499144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient drug prescribing related to clinic utilization in four New York City hospitals.
    Muller C
    Health Serv Res; 1968; 3(2):142-54. PubMed ID: 5686352
    [No Abstract]   [Full Text] [Related]  

  • 17. [The incidence of drug side effects with reference to organ systems. Experience of the spontaneous reporting system of the Swiss Drug Side Effect Center and Comprehensive Drug Monitoring].
    Kuhn M; Hartmann K; Maibach R; Capaul R; Gartmann JC
    Ther Umsch; 1993 Jan; 50(1):8-12. PubMed ID: 8378869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Self-assessment by physicians concerning their management of drug risks. Information sources, risk evaluation, problems and recommendations for improvements].
    Kemmnitz W
    Z Arztl Fortbild Qualitatssich; 1998 Sep; 92(7):509-12. PubMed ID: 9842698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reactions: a review for healthcare practitioners.
    Young LR; Wurtzbacher JD; Blankenship CS
    Am J Manag Care; 1997 Dec; 3(12):1884-906; quiz 1909-10. PubMed ID: 10178476
    [No Abstract]   [Full Text] [Related]  

  • 20. [Detection of drug side effects at the Heidelberg Medical Clinic].
    Jacubeit T; Drisch D
    Verh Dtsch Ges Inn Med; 1989; 95():690-3. PubMed ID: 2603505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.